April 23, 2012 (Atlanta, GA) — Methadone and buprenorphine are viable analgesic treatment options for patients with chronic pain and comorbid opioid addiction. However, when it comes to safety, ...

With the opioid epidemic reaching into every corner of the U.S., more people are talking about addiction as a chronic disease rather than a moral failing. For researcher A. Thomas McLellan, who has ...

Living with chronic pain is a challenge affecting millions of people daily. From back pain to arthritis, fibromyalgia to migraines, finding relief often requires a multifaceted approach. One of the ...

Key Takeaways Evidence-based therapies for alcohol addiction have scientific validation behind them, making them more ...

A new study finds chronic pain patients show a high prevalence of addiction to prescription pain medications, according to a news release by Geisinger Health System. The study by Geisinger researchers ...

A new scientific review of 148 studies enrolling over 4.3 million adult chronic pain patients treated with prescription opioid painkillers has found that nearly one in ten patients experiences opioid ...

Nearly 1 in every 10 chronic pain patients treated with prescription opioids winds up addicted to the painkillers at some point, a new review finds. Further, nearly 1 in 3 will show symptoms of opioid ...

Natasha Lyonne has revealed a relapse after more than a decade of sobriety, sharing her experience publicly to encourage ...

AUSTIN (KXAN) – “When I was on pain meds and in pain all the time, you’re going through hell, and you are really just trying to make it sometimes, one hour at a time,” said Eric Bumpus, a 43-year-old ...

Experts agree that addiction is a disease, yet the disease model doesn't capture addiction's harmful effects on others.

KXAN’s Jose Torres shares the story of 43-year-old Eric Bumpus, husband and father of two. Bumpus reflects on five years of living with an addiction to pain pills. He shared when he was on pain meds ...

The new method is designed to focus specifically on pain-related signals, without interfering with normal activity in other parts of the brain. A new preclinical study has identified a gene therapy ap ...